Novo Image - Search News

News

Novo Nordisk Stock Drops

Novo Nordisk (NYSE: NVO) stock imitated the company's leading product on Wednesday by slimming down in price. The Danish pharmaceutical's shares lost nearly 4% of their value following its latest earnings release,

AOL · 5d

Why Novo Nordisk Stock Bumped Higher on Friday

Both Novo Nordisk's Wegovy and rival Eli Lilly's Zepbound are essentially versions of predecessor diabetes drugs. Some private insurance plans cover obesity medications. The Post wrote that the experimental program will last for five years.

Wall Street Journal · 14h

Novo Nordisk, TSMC, Glencore: Stocks Around the World in Focus

The pharmaceutical company's quarterly sales of its blockbuster Wegovy drug surged by two-thirds, despite many Americans [using copycat versions](

GlobalData on MSN8h

Novo Nordisk to advance ATTR amyloidosis mAb to Phase III

Novo Nordisk will advance its acquired ATTR amyloidosis with cardiomyopathy monoclonal antibody (mAb) to Phase III trials.

Devdiscourse14h

Novo Nordisk Faces Challenges as Copycat Competition Intensifies

Novo Nordisk experiences heightened competition from copycat versions of its Wegovy obesity drug, affecting its market share, ...

Zacks Investment Research on MSN9h

Novo Nordisk Q2 Earnings Beat, Sales Miss, GLP-1 Drugs Face US Hurdles

Novo Nordisk A/S NVO reported second-quarter 2025 earnings of 97 cents per American Depositary Receipt (ADR), which beat the ...

Ozempic Maker’s Stock Plunges 20% After Profit Warning

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...

Devdiscourse11h

Novo Nordisk's Wegovy Showdown: Navigating Market Pressures and Potential Layoffs

Novo Nordisk faces a critical phase with its obesity drug Wegovy as it confronts competition from Eli Lilly and potential job ...

News Medical14y

Lilly and Novo Nordisk have the best diabetes corporate image: Study

Endocrinologists, primary care physicians (PCPs) and nurse educators perceive Lilly and Novo Nordisk to have the best diabetes corporate image, with Lilly slightly outscoring Novo among ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results